Streetbeat News

Analyst Ratings

CHS

Telsey Advisory Group has maintained a 'Market Perform' rating on Chico's FAS (NYSE:CHS) and raised the price target from $6 to $7.6.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:49 am

SHW

Berenberg analyst Adrien Tamagno maintains a 'Hold' rating on Sherwin-Williams (NYSE:SHW) and raises the price target from $224 to $249.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:34 am

NKE

Telsey Advisory Group analyst Joseph Feldman has reiterated an 'Outperform' rating on Nike (NYSE:NKE) and maintained a price target of $128.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:33 am

NKE

Deutsche Bank analyst Gabriella Carbone maintains a 'Buy' rating on Nike and raises the price target from $122 to $125.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:31 am

CUBI

Raymond James analyst Steve Moss has initiated coverage on Customers Bancorp (NYSE:CUBI) with a Strong Buy rating and a price target of $60.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:30 am

JAZZ

Raymond James analyst Gary Nachman has initiated coverage on Jazz Pharmaceuticals with a Market Perform rating.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:26 am

LCID

RIVN

Electric vehicle (EV) startups Rivian Automotive, Inc. (NASDAQ:RIVN) and Lucid Group, Inc. (NASDAQ:LCID) have struggled with production ramp-up and stock price performance over the past year. However, data suggests potential for improvement. A $100 investment in Rivian a year ago is currently worth $71.43, while the same investment in Lucid would be worth $38.97. Despite these losses, analysts are hopeful for a rebound, particularly as oversold levels provide a platform for potential growth. Rivian's stock rose 0.13% to $23.08 and Lucid's gained 1.28% to close at $5.53.

Portfolio Pulse from Shanthi Rexaline

September 29, 2023 | 9:20 am

IONS

Raymond James has initiated coverage on Ionis Pharmaceuticals with a Strong Buy rating and a price target of $63.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:19 am

NICE

DA Davidson analyst Gil Luria initiates coverage on NICE (NASDAQ:NICE) with a Neutral rating and announces a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:10 am

INGR

Oppenheimer analyst Kristen Owen has initiated coverage on Ingredion (NYSE:INGR) with an Outperform rating and a price target of $120.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 9:05 am